IBD Collaborative 2.13.20

February 13, 2020

Target Audience

Nurse

Nurse Practitioner

Physician

Physician Assistant

Psychologist

Social Worker

Learning Objectives

Identify advanced treatment modalities for the treatment of severe Crohn's disease. Explore and debate novel endoscopic treatments for Crohn's disease patients. Promote multidisciplinary education among providers caring for Inflammatory Bowel Disease (IBD) patients.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.50 Attendance
Course opens: 
02/07/2020
Course expires: 
06/30/2020
Event starts: 
02/13/2020 - 5:30pm EST
Event ends: 
02/13/2020 - 8:15pm EST
Add to calendar: 

5:30   Reception:  Networking & Exhibits

 

6:15   Dinner Buffet Opens (bar to close at 7:00)

 

6:40   Welcome:  IBD Collaborative Course Co-Directors

  • Sandra El-Hachem, MD – Case Presenter
  • Marc Schwartz, MD - Moderator

 

Case Presentation:  CD with Pain & Stricture                    

Endoscopic Management of Crohn’s Stricture                 Gursimran S. Kochhar, MD

Debate: 

First Line Medical Therapy vs Surgical Therapy for Complicated Crohn’s Disease         Furkan Ertem, MD and Marisa Isaacson, MD 

Q&A and Audience Discussion

 

8:15   Adjourn

Rivers Club
Pittsburgh, PA
United States

 

Sandra El-Hachem, MD  is a member of the  CE Speakers’ Bureau for the following companies: Abbvie, Janssen Biotech, Pfizer, Takeda,  and UCB

 

 

Furkan Ertem, MD

Gastroenterology & Hepatology Fellow, Year I

University of Pittsburgh | UPMC

 

Sandra El-Hachem, MD

Clinical Assistant Professor of Medicine

Director, IBD Center and Section Head, Integrative Medicine

Allegheny Health Network | Temple University

Course Co-Director, IBD Collaborative

 

Marisa Isaacson, MD

Gastroenterology & Hepatology Fellow

Allegheny Health Network

 

Gursimran S. Kochhar, MD, FACP, CNSC

Interventional IBD & Therapeutic Endoscopist

Allegheny Health Network

 

Marc Schwartz, MD

Assistant Professor of Medicine

Clinical Director, IBD Center

Division of Gastroenterology, Hepatology and Nutrition

University of Pittsburgh | UPMC

Course Co-Director, IBD Collaborative

Faculty Disclosure

No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.

Accreditation and credit designation

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)

The University of Pittsburgh School designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Other Healthcare Professionals

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.50 Attendance

ABBVIE, INC.

Alfasigma USA, Inc

Ferring Pharmaceuticals, Inc.

Janssen Biotech

Medtronic

Pfizer (1)

Pfizer, Inc. (2)

Prometheus Biosciences

Shire US Inc.

Takeda

Please login or register to take this course.